Aspen Aerogels (ASPN) Competitors $8.04 -0.12 (-1.41%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ASPN vs. CENT, GLP, VSTS, WKC, DSGR, GIC, STKL, CAPL, MGPI, and ITRNShould you be buying Aspen Aerogels stock or one of its competitors? The main competitors of Aspen Aerogels include Central Garden & Pet (CENT), Global Partners (GLP), Vestis (VSTS), World Kinect (WKC), Distribution Solutions Group (DSGR), Global Industrial (GIC), SunOpta (STKL), CrossAmerica Partners (CAPL), MGP Ingredients (MGPI), and Ituran Location and Control (ITRN). These companies are all part of the "wholesale" industry. Aspen Aerogels vs. Central Garden & Pet Global Partners Vestis World Kinect Distribution Solutions Group Global Industrial SunOpta CrossAmerica Partners MGP Ingredients Ituran Location and Control Aspen Aerogels (NYSE:ASPN) and Central Garden & Pet (NASDAQ:CENT) are both construction companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability. Does the media refer more to ASPN or CENT? In the previous week, Aspen Aerogels had 32 more articles in the media than Central Garden & Pet. MarketBeat recorded 35 mentions for Aspen Aerogels and 3 mentions for Central Garden & Pet. Central Garden & Pet's average media sentiment score of 0.89 beat Aspen Aerogels' score of -0.25 indicating that Central Garden & Pet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aspen Aerogels 2 Very Positive mention(s) 7 Positive mention(s) 4 Neutral mention(s) 14 Negative mention(s) 0 Very Negative mention(s) Neutral Central Garden & Pet 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, ASPN or CENT? Central Garden & Pet has higher revenue and earnings than Aspen Aerogels. Central Garden & Pet is trading at a lower price-to-earnings ratio than Aspen Aerogels, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspen Aerogels$452.70M1.46$13.38M$0.1650.44Central Garden & Pet$3.22B0.76$107.98M$1.8220.44 Does the MarketBeat Community prefer ASPN or CENT? Aspen Aerogels received 124 more outperform votes than Central Garden & Pet when rated by MarketBeat users. Likewise, 65.63% of users gave Aspen Aerogels an outperform vote while only 60.09% of users gave Central Garden & Pet an outperform vote. CompanyUnderperformOutperformAspen AerogelsOutperform Votes38065.63% Underperform Votes19934.37% Central Garden & PetOutperform Votes25660.09% Underperform Votes17039.91% Is ASPN or CENT more profitable? Central Garden & Pet has a net margin of 3.77% compared to Aspen Aerogels' net margin of 2.95%. Central Garden & Pet's return on equity of 10.08% beat Aspen Aerogels' return on equity.Company Net Margins Return on Equity Return on Assets Aspen Aerogels2.95% 7.49% 5.10% Central Garden & Pet 3.77%10.08%4.38% Do analysts prefer ASPN or CENT? Aspen Aerogels currently has a consensus target price of $22.44, indicating a potential upside of 178.12%. Central Garden & Pet has a consensus target price of $46.75, indicating a potential upside of 25.64%. Given Aspen Aerogels' higher probable upside, equities research analysts plainly believe Aspen Aerogels is more favorable than Central Garden & Pet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspen Aerogels 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Central Garden & Pet 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.20 Which has more risk & volatility, ASPN or CENT? Aspen Aerogels has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, Central Garden & Pet has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Do insiders & institutionals have more ownership in ASPN or CENT? 97.6% of Aspen Aerogels shares are owned by institutional investors. Comparatively, 16.1% of Central Garden & Pet shares are owned by institutional investors. 4.3% of Aspen Aerogels shares are owned by company insiders. Comparatively, 8.2% of Central Garden & Pet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAspen Aerogels beats Central Garden & Pet on 10 of the 19 factors compared between the two stocks. Get Aspen Aerogels News Delivered to You Automatically Sign up to receive the latest news and ratings for ASPN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASPN vs. The Competition Export to ExcelMetricAspen AerogelsLumber & other construction materials IndustryConstruction SectorNYSE ExchangeMarket Cap$660.09M$2.97B$8.47B$20.03BDividend YieldN/A0.71%1.94%3.65%P/E Ratio50.2818.9115.5634.84Price / Sales1.460.8266.6715.64Price / CashN/A6.4122.1920.85Price / Book1.162.304.424.92Net Income$13.38M$236.37M$536.25M$1.02B7 Day Performance-6.88%-8.25%-2.91%-1.10%1 Month Performance-30.88%-17.90%-6.02%-1.44%1 Year Performance-51.76%-26.36%36.60%13.91% Aspen Aerogels Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASPNAspen Aerogels3.5634 of 5 stars$8.07-1.0%$22.44+178.1%-52.2%$660.09M$452.70M50.28420Analyst ForecastAnalyst RevisionCENTCentral Garden & Pet3.7021 of 5 stars$38.75-0.9%$46.75+20.6%-14.2%$2.54B$3.20B21.296,450Analyst RevisionGLPGlobal Partners1.7922 of 5 stars$57.50+0.6%$54.00-6.1%+27.5%$1.96B$16.49B17.375,060Upcoming EarningsVSTSVestis2.2468 of 5 stars$13.71-0.1%$14.08+2.7%-30.3%$1.81B$2.81B171.4510,800Positive NewsWKCWorld Kinect2.9348 of 5 stars$27.32-3.0%$30.20+10.5%+15.0%$1.59B$47.71B12.145,289Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpDSGRDistribution Solutions Group3.2398 of 5 stars$30.44+0.1%$43.00+41.3%-8.5%$1.43B$1.57B761.191,685GICGlobal Industrial4.4778 of 5 stars$24.29+0.7%N/A-44.7%$928.68M$1.27B14.291,870Analyst RevisionSTKLSunOpta3.6186 of 5 stars$7.64+2.0%$9.50+24.3%+19.7%$914.13M$630.30M-42.441,174Positive NewsCAPLCrossAmerica Partners2.1981 of 5 stars$22.72+0.4%N/A+6.7%$864.50M$4.39B43.692,220Positive NewsMGPIMGP Ingredients4.6323 of 5 stars$33.15+2.4%$71.29+115.0%-64.9%$727.64M$836.52M6.89690ITRNIturan Location and Control3.5957 of 5 stars$35.58+2.9%N/A+59.9%$707.69M$319.98M13.632,841Upcoming Earnings Related Companies and Tools Related Companies Central Garden & Pet Alternatives Global Partners Alternatives Vestis Alternatives World Kinect Alternatives Distribution Solutions Group Alternatives Global Industrial Alternatives SunOpta Alternatives CrossAmerica Partners Alternatives MGP Ingredients Alternatives Ituran Location and Control Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ASPN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Aerogels, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspen Aerogels With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
